Publications by authors named "Irem Pembegul"
Article Synopsis
- * About 9.8% of the patients died during hospitalization, with older individuals and those with preexisting kidney issues showing higher mortality rates due to severe injuries and complications.
- * Key factors influencing mortality included age, injury severity, shock, and certain elevated lab values, highlighting the need for better disaster preparedness and health care improvements for future events.
Article Synopsis
- Millions are affected by natural disasters annually, leading to serious medical issues like crush syndrome, which often results in acute kidney injury tied to high mortality rates.
- This study analyzed data from 1024 patients with crush syndrome after the February 2023 earthquakes in Kahramanmaras, focusing on their treatment and outcomes in Turkish hospitals.
- The findings revealed high rates of acute kidney injury and hemodialysis treatment, with a 9.8% in-hospital mortality rate, highlighting the urgent need for improved emergency response training and protocols for managing kidney health in disaster scenarios.
Introduction: Peritoneal dialysis (PD) remains understudied in disaster nephrology. This retrospective multicenter study explores the experiences of PD survivors following the February 6, 2023, KahramanmaraÅŸ Earthquake.
Methods: Adult PD patients from 11 affected cities were analyzed to assess challenges faced during and postearthquake, alongside clinical outcomes.
Objective: The aim of this study was to reveal the relationship between hemodialysis (HD) adequacy and dialysis symptom index (DSI) in patients with end-stage kidney disease (ESKD).
Methods: This prospective study included 92 ESKD patients who underwent HD three times a week. Data including sex, age, education status, marital status, economic status, employment status, dependency status, type of vascular access, and duration of HD were recorded.
Purpose: Coronavirus disease 2019 (COVID-19) has a higher mortality in the presence of chronic kidney disease (CKD). However, there has not been much research in the literature concerning the outcomes of CKD patients in the post-COVID-19 period. We aimed to investigate the outcomes of CKD patients not receiving renal replacement therapy.
View Article and Find Full Text PDFIntroduction: Hemodialysis (HD) patients have increased risk for short-term adverse outcomes of COVID-19. However, complications and survival at the post-COVID-19 period have not been published extensively.
Methods: We conducted a national, multicenter observational study that included adult maintenance HD patients recovered from confirmed COVID-19.
Introduction: COVID-19 pneumonia typically presents with high fever, cough, and shortness of breath and on thorax computed tomography (CT) peripheral ground glass opacities help the diagnosis. Although typical imaging findings for COVID-19 pneumonia are specified in thorax CT, these findings can be confused with other diseases. The aim of this study is to investigate the roles of radiological imaging and laboratory findings in the differential diagnosis of COVID-19 pneumonia and acute heart failure (AHF).
View Article and Find Full Text PDFObjective: Older adults with co-morbidities have been reported to be at higher risk for adverse outcomes of coronavirus disease 2019 (COVID-19). The characteristics of COVID-19 in older patients and its clinical outcomes in different kidney disease groups are not well known.
Methods: Data were retrieved from a national multicentric database supported by Turkish Society of Nephrology, which consists of retrospectively collected data between 17 April 2020 and 31 December 2020.
Background: Chronic kidney disease (CKD) and immunosuppression, such as in renal transplantation (RT), stand as one of the established potential risk factors for severe coronavirus disease 2019 (COVID-19). Case morbidity and mortality rates for any type of infection have always been much higher in CKD, haemodialysis (HD) and RT patients than in the general population. A large study comparing COVID-19 outcome in moderate to advanced CKD (Stages 3-5), HD and RT patients with a control group of patients is still lacking.
View Article and Find Full Text PDFBackground: Mycophenolate mofetil (MMF) has shown to be a reliable choice in the treatment of glomerulonephritis. We retrospectively reviewed the clinical course and response to MMF therapy in 49 patients with primary glomerulopathy (37 patients) and lupus nephritis [class III (five patients) and IV (seven patients)].
Methods: Patients were treated with MMF for more than 6 months as a primary (18 patients) or an adjunctive treatment (31 patients).